The aim of the present trial is to investigate a new option of skin protection in order to reduce the rate of grade ≥ 2 skin toxicity in patients receiving radiotherapy alone or radiochemotherapy for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN). | Radiotherapy related skin toxicity RAREST-01 Mepitel film versus standard care in patients with locally advanced head-and-neck cancer